These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 6455501)

  • 1. The endocrine profile of bromocriptine: its application in endocrine diseases.
    Lancranjan I
    J Neural Transm; 1981; 51(1-2):61-82. PubMed ID: 6455501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of ovine corticotrophin releasing factor (oCRF), bromocriptine and TRH on the secretion of ACTH and alpha-MSH in Nelson's syndrome and Cushing's disease.
    Abraham RR; Campbell EA; Gillham B; Thody AJ; Altaher AR; Prysor-Jones A; Wynn V; Jones MT; Jenkins J
    Clin Endocrinol (Oxf); 1986 Jul; 25(1):75-85. PubMed ID: 3024873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperprolactinemia in Cushing's disease and Nelson's syndrome.
    Yamaji T; Ishibashi M; Teramoto A; Fukushima T
    J Clin Endocrinol Metab; 1984 May; 58(5):790-5. PubMed ID: 6323516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth hormone and prolactin responses to corticotrophin-releasing-hormone in patients with Cushing's disease: a paracrine action of the adenomatous corticotrophic cells?
    Loli P; Boccardi E; Branca V; Bramerio M; Barberis M; Losa M; Terreni MT; Lodrini S; Pollo B; Vignati F
    Clin Endocrinol (Oxf); 1998 Oct; 49(4):433-9. PubMed ID: 9876339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Profound amplification of secretory-burst mass and anomalous regularity of ACTH secretory process in patients with Nelson's syndrome compared with Cushing's disease.
    van Aken MO; Pereira AM; van den Berg G; Romijn JA; Veldhuis JD; Roelfsema F
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):765-72. PubMed ID: 15163342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The mechanism of the suppressive action of bromocriptine on adrenocorticotropin secretion in patients with Cushing's disease and Nelson's syndrome.
    Lamberts SW; Klijn JG; de Quijada M; Timmermans HA; Uitterlinden P; de Jong FH; Birkenhäger JC
    J Clin Endocrinol Metab; 1980 Aug; 51(2):307-11. PubMed ID: 6249835
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of the somatostatin analog SMS 201-995 on normal growth hormone secretion in the rat. A comparison with the effect of bromocriptine on normal prolactin secretion.
    Lamberts SW; Verleun T; Zuiderwijk JM; Oosterom R
    Acta Endocrinol (Copenh); 1987 Jun; 115(2):196-202. PubMed ID: 2885995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of valproic acid, naloxone and hydrocortisone in Nelson's syndrome and cushing's disease.
    Elias AN; Gwinup G; Valenta LJ
    Clin Endocrinol (Oxf); 1981 Aug; 15(2):151-4. PubMed ID: 6273025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pituitary surgery for endocrine disorders.
    Nabarro JD
    Clin Endocrinol (Oxf); 1980 Sep; 13(3):285-98. PubMed ID: 7011598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different responses of growth hormone secretion to guanfacine, bromocriptine, and thyrotropin-releasing hormone in acromegalic patients with pure growth hormone (GH)-containing and mixed GH/prolactin-containing pituitary adenomas.
    Lamberts SW; Klijn JG; van Vroonhoven CC; Stefanko SZ
    J Clin Endocrinol Metab; 1985 Jun; 60(6):1148-53. PubMed ID: 3923021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of prolactin in the inhibitory action of bromocriptine on growth hormone secretion in acromegaly.
    Lamberts SW; Klijn JG; van Vroonhoven CC; Stefanko SZ; Liuzzi A
    Acta Endocrinol (Copenh); 1983 Aug; 103(4):446-50. PubMed ID: 6310918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ACTH secretory responsiveness of pituitary adrenotroph cell tumor to adrenocorticotropin-releasing factor in Cushing's disease and Nelson's syndrome.
    Takeda R; Ito T; Kawato M; Nakabayashi H; Miyamori I; Morise T; Koshida H; Ikeda M
    Exp Clin Endocrinol; 1986 Jun; 87(1):31-7. PubMed ID: 3017732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma ACTH and cortisol responses to TRF, vasopressin or hypoglycemia in cushing's disease and nelson's syndrome.
    Krieger DT; Luria M
    J Clin Endocrinol Metab; 1977 Feb; 44(2):361-8. PubMed ID: 190254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Studies of the basal secretion and the response to TRH (thyrotropin-relapsing factor) of TSH (thyrotropin) and prolactin in Cushing's syndrome and Nelson's syndrome (author's transl)].
    Luton JP; Molinie P; Strauch G; Guilhaume B; Bricaire H
    Sem Hop; 1981 May 8-15; 57(17-18):841-9. PubMed ID: 6262921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of changes in the plasma ACTH level on the prolactin response to metoclopramide or bromocriptine in normal subjects and patients with Nelson's syndrome.
    Nishida S; Matsuki M; Nagase Y; Horino M; Endoh M; Kakita K; Tenku A; Oyama H
    Horm Metab Res; 1984 Feb; 16(2):107-8. PubMed ID: 6323292
    [No Abstract]   [Full Text] [Related]  

  • 16. Prolactin secretion by mixed ACTH-prolactin pituitary adenoma cells in culture.
    Yamaji T; Ishibashi M; Teramoto A; Fukushima T
    Acta Endocrinol (Copenh); 1985 Apr; 108(4):456-63. PubMed ID: 2859725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corticotropin-releasing hormone (CRH) stimulation in Nelson's syndrome: response of adrenocorticotropin secretion to pulse injection and continuous infusion of CRH.
    Oldfield EH; Schulte HM; Chrousos GP; Gold PW; Benker G; Peterson RE; Cutler GB; Loriaux DL
    J Clin Endocrinol Metab; 1986 May; 62(5):1020-6. PubMed ID: 3007552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cushing's disease and hyperprolactinemia due to a mixed ACTH- and prolactin-secreting pituitary macroadenoma.
    Mahler C; Verhelst J; Klaes R; Trouillas J
    Pathol Res Pract; 1991 Jun; 187(5):598-602. PubMed ID: 1656408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture.
    Ishibashi M; Yamaji T
    J Clin Invest; 1984 Jan; 73(1):66-78. PubMed ID: 6140273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multihormonal response to CRH in a patient with Cushing syndrome and a pituitary adenoma producing ACTH and GH.
    Bugalho MJ; Nunes JF; Sobrinho LG; Medina E; Campos JA; da Silva CG; Clode AL
    Acta Endocrinol (Copenh); 1993 Mar; 128(3):289-92. PubMed ID: 8386895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.